Law Firm Probes Option Care Health Over Shareholder Rights
Monteverde & Associates is investigating Option Care Health amid potential shareholder concerns. The M&A-focused class action firm has recovered millions for investors.
A New York-based securities law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), scrutinizing whether the home infusion therapy company's leadership has adequately protected shareholder interests, according to an announcement released October 11, 2026.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, is spearheading the probe. The firm, which describes itself as an M&A-focused class action practice, was recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report and has previously recovered millions of dollars on behalf of shareholders in similar matters.
Read more Law Firm Probes Option Care Health Shareholder Rights (OPCH) →
Investigations of this type typically arise when a law firm believes a company's board of directors may have breached fiduciary duties — commonly in connection with a proposed merger, acquisition, or other corporate transaction that could affect shareholder value. The announcement did not detail the specific transaction or conduct under review at Option Care Health.
Shareholders of OPCH who wish to learn more about their legal rights or potential recovery options are generally encouraged to contact the investigating firm directly. No lawsuit has been filed, and an investigation does not constitute a legal finding of wrongdoing against the company or its executives.
Continue reading at All Financial Services & Investing.
